Not Signed In -
Quetiapine |
Seroquel |
Clinical Trial: Interaction between Cocaine and Quetiapine - 1
This study is no longer recruiting patients.
Purpose
The purpose of this study is to assess the safety of intravenous (IV) cocaine in subjects taking quetiapine at 3 dosage levels.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Cocaine-Related Disorders | Drug: Quetiapine | Phase I |
MedlinePlus related topics: Cocaine Abuse
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Safety Study
Official Title: Interaction Between IV Cocaine and Quetiapine
Expected Total Enrollment: 12
Study start: October 2003
A placebo-controlled, double-blind, inpatient assessment of interaction between intravenous cocaine and quetiapine (seroquel) in cocaine-experienced subjects. To assess the safety of IV cocaine in subjects taking quetiapine at 3 dosage levels.
Eligibility
Ages Eligible for Study: 18 Years - 45 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
Includes but is not limited to: non-treatment seeking individuals. Must meet DSM-IV criteria for cocaine abuse or dependence. Must be able to verbalize understanding of consent and provide written informed consent and verbalize willingness to complete study procedures. Site will provide further details.
Exclusion Criteria:
Please contact site for further information
Location Information
Massachusetts
Boston University Medical Center, Boston, Massachusetts, 02215, United States
Domenic Ciraulo, M.D., Principal Investigator, Boston University School of Medicine
More Information
Record last reviewed: March 2005
Last Updated: March 24, 2005
Record first received: July 13, 2004
ClinicalTrials.gov Identifier: NCT00087750
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
